Skip to main content
SpringerLink
Log in

Zweitlinienbehandlung

Sunitinib bewährt sich bei GIST

  • neues aus der forschung
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Reichardt P et al. Clinical Outcomes of Patients With Advanced Gastrointestinal Stromal Tumors: Safety and Efficacy in a Worldwide Treatment-Use Trial of Sunitinib. Cancer. 2015 Jan 13 [Epub ahead of print].

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Peter Leiner

Authors
  1. Peter Leiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leiner, P. Sunitinib bewährt sich bei GIST. Info Onkol. 18, 27 (2015). https://doi.org/10.1007/s15004-015-0769-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-015-0769-x

Search

Navigation